ABSTRACT:

The global incidence and prevalence of type 2 diabetes mellitus has continued to increase over the past three decades and is expected to triple by 2030.1 Based on data from the World Health Organization (WHO), in 2021, 1.28 billion adults worldwide have hypertension.4 In relation to type 2 DM therapy, patient non-compliance in undergoing treatment can cause failure to control blood sugar levels and can cause cardiovascular complications.5
Objective: To determine the relationship between adherence to medication consumption in people with type 2 diabetes mellitus and the incidence of hypertension.
Methods: This study used an analytical descriptive method with cross sectional design. Sampling used consecutive sampling techniques with the sample size obtained using the Slovin formula, where the population was 447, resulting in a total sample of 218 respondents who made the inclusion and exclusion criteria. Primary data was obtained from the Medication Adherence Rating Scale-10 (MARS-10) questionnaire which was filled in by the respondent and the respondent’s blood pressure was checked by automatic sphygmomanometer Kenz AC-05P. Data was analyzed using SPSS-25 software with the chi- square test.
Results: From 218 respondents, 80 respondents were non-adherent in taking medication and suffered from hypertension (90.9%) and 8 respondents were non-adherent in taking medication and did not suffer from hypertension (9.1%). There were 29 respondents who adhered to taking medication and suffered from hypertension (22.3%) and 101 respondents who adhered to taking medication and did not suffer from hypertension (77.7%). These results obtained a p-value of 0.000 <0.05, which means there is a relationship between adherence to drug consumption in patients with type 2 diabetes mellitus and the incidence of hypertension.
Conclusion: There is a relationship between adherence to drug consumption in patients with type 2 diabetes mellitus and the occurrence of hypertension at Puskesmas Sentosa Baru and Puskesmas Sering in Medan City.

KEYWORDS:

Adherence, Hypertension, Type 2 diabetes mellitus

REFERENCES :

1) Perkumpulan Endokrinologi Indonesia (PERKENI). 2021. Pedoman dan Pencegahan Diabetes Mellitus Tipe 2 di Indonesia 2021. Jakarta: PB PERKENI
2) Internasional Diabetes Federation. 2021. IDF Diabetes Atlas. Ed 10th.
3) Kementerian Kesehatan Republik Indonesia. 2018. Riset Kesehatan Dasar 2018. Jakarta: Kemenkes RI
4) World Health Organization. Hypertension 2021 [Available from: 

https://www.who.int/news-room/fact-sheets/detail/hypertension Accessed 30 August 2023]
5) Saibi, Yardi, Rizki Romadhon, and Narila Mutia Nasir. 2020. “Kepatuhan Terhadap Pengobatan Pasien Diabetes Melitus Tipe 2 Di Puskesmas Jakarta Timur.” Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) 6(1):94–103. 

doi: 10.22487/j24428744.2020.v6.i1.15002.
6) Mokolomban, Citri, Weny I. Wiyono, and Deby A. Mpila. 2018. “Kepatuhan Minum Obat. Pada Pasien Diabetes Melitus Tipe 2 Disertai Hipertensi Dengan Menggunakan Metode Mmas-8.” Pharmacon 7(4):69–78.
7) Baah-Nyarkoh, Emmanuella, Yakubu Alhassan, Andrews K. Dwomoh, and Irene A. Kretchy. 2023. “Medicated-Related Burden and Adherence in Patients with Co-Morbid Type 2 Diabetes Mellitus and Hypertension.” Heliyon 9(4):e15448.

 doi: 10.1016/j.heliyon.2023.e15448.
8) Wibowo, M. I. N. A, Fitri, F., Yasin, N., Kristina, S. and Prabandari, Y. (2021) “Kepatuhan Minum Obat pada Pasien Diabetes Melitus Tipe 2 di Beberapa Puskesmas Kabupaten Banyumas”, Jurnal Kefarmasian Indonesia, 11(2), pp. 98-108. 

doi: 10.22435/jki.v11i2.3635.
9) Gumilas NSA, Harini IM, Samodra P, Ernawati DA. Karakteristik Penderita Diabetes Melitus (Dm) Tipe 2 Di Purwokerto. J Kesehat. 2018;1(2):14–5.
10) Amani, Miska, Siti Annisa Devi Trusda, and Samsudin Surialaga. 2023. “Gambaran Karakteristik Pasien Diabetes Melitus Tipe 2 Dengan Hipertensi Di RSUD Al Ihsan Bandung.” Bandung Conference Series: Medical Science 3(1):482–88.

 doi: 10.29313/bcsms.v3i1.6277.
11) Fitriyani, Novita Endang, Iva Rinia Dewi, Mersi Nawangsari Jurnal, Penelitian Sains, Dan Kesehatan, Avicenna Jurnal, Kesehatan Avicenna, Mersi Nawangsari, Prodi D3, Analis Farmasi, Dan Makanan, Stikes Ibnu, Sina Ajibarang, and Info Artikel Abstrak. 2023. “Tingkat Kepatuhan Penggunaan Obat Pada Pasien Diabetes Melitus Tipe 2 Program Rujuk Balik Apotek Kimia Farma 437 Di Kota Purwokerto.” 2(2):8–15.
12) Rahmawati, Indri. 2023. “Karakteristik Diabetes Melitus Tipe 2 Berdasarkan Usia, Jenis Kelamin Dan Profil Lipid Di Rumah Sakit Umum Daerah Subang.” Bandung Conference Series: Medical Science 3(1):384–90. doi: 10.29313/bcsms.v3i1.6132.
13) Kurniawaty, Evi. 2014. “Diabetes Mellitus.” Evi Kurniawaty JUKE 4(7):114–19. Lanra, Fima, Fredrik Gerald, Afnal Asrifuddin, Fakultas Kesehatan, Masyarakat Universitas, and Sam Ratulangi. 2019. “Hubungan Antara Terkontrol Tidaknya Diabetes Mellitus Tipe 2 Dengan Kualitas Hidup Di Puskesmas Girian Weru Kota Bitung.” Kesmas 8(7):430–36.
14) Militia, Fibra, Sarah Handayani, and Bambang Setiaji. 2021. “Kejadian Diabetes Mellitus Tipe II Pada Lanjut Usia Di Indonesia (Analisis Riskesdas 2018 ).” Jurnal Kedokteran Dan Kesehatan 17(1):9–20.
15) Tramunt, Blandine, Alexia Rouland, Vincent Durlach, Bruno Vergès, Daniel Thomas, Ivan Berlin, and Carole Clair. 2023. “Smoking and Diabetes: Sex and Gender Aspects and Their Effect on Vascular Diseases.” Canadian Journal of Cardiology 39(5):681–92. doi: 10.1016/j.cjca.2023.01.018.
16) Sari, Mutiara Indah, Nisrina Sari, Dewi Masyithah Darlan, and Raka Jati Prasetya. 2018. “Cigarette Smoking and Hyperglycaemia in Diabetic Patients.” Open Access Macedonian Journal of Medical Sciences 6(4):634–37. doi: 10.3889/oamjms.2018.140.
17) Nazriati, Elda, Diana Pratiwi, and Tuti Restuastuti. 2018. “Pengetahuan Pasien Diabetes Melitus Tipe 2 Dan Hubungannya Dengan Kepatuhan Minum Obat Di Puskesmas Mandau Kabupaten Bengkalis.” Majalah Kedokteran Andalas 41(2):59.

 doi: 10.25077/mka.v41.i2.p59-68.2018.
18) Pertiwi, Maria Vini, Riza Alfian, Yunita Nita, and Umi Athiyah. 2022. “Medication Adherence of Diabetes Mellitus Patients in Indonesia: A Systematic Review.” Pharmacy Education 22(2):188–93. doi: 10.46542/pe.2022.222.188193.
19) Prabowo, Ratna Herawati. 2019. “Prevalensi Hipertensi Pada Pasien Diabetes Melitus Di Kelurahan Mojosongo Kota Surakarta.” Biomedika 12(1):41–46.

 doi: 10.31001/biomedika.v12i1.471.
20) Naseri, Mohammad Wali, Habib Ahmad Esmat, and Mohammad Daud Bahee. 2022. “Prevalence of Hypertension in Type-2 Diabetes Mellitus.” Annals of Medicine and Surgery 78(May):103758. doi: 10.1016/j.amsu.2022.103758.
21) Oktaviyani, Prisilia, Marlynda Happy, Nurmalita Sari, Melisa Frisilia, and Ana Satria. 2022. “Prevalence and Risk Factors of Hypertension and Diabetes Mellitus among the Indonesian Elderly.” Makara Journal of Health Research 26(1):26–32.

 doi: 10.7454/msk.v26i1.1329.
22) Abdelbagi, Omer, Imad R. Musa, Shaza M. Musa, Salim A. ALtigani, and Ishag Adam. 2021. “Prevalence and Associated Factors of Hypertension among Adults with Diabetes Mellitus in Northern Sudan: A Cross-Sectional Study.” BMC Cardiovascular Disorders 21(1):1–7. doi: 10.1186/s12872-021-01983-x.
23) Flood, David, Elizabeth W. Edwards, David Giovannini, Emily Ridley, Andres Rosende, William H. Herman, Marc G. Jaffe, and Donald J. DiPette. 2022. “Integrating Hypertension and Diabetes Management in Primary Health Care Settings: HEARTS as a Tool.” Revista Panamericana de Salud Publica/Pan American Journal of Public Health 46:1–9. 

doi: 10.26633/RPSP.2022.150. 
24) Wati. 2021. “Pasien Hipertensi Dengan Penyerta Diabetes Mellitus.” Media Husada Journal of Nursing Science 2(2):28–34.
25) Kementerian Kesehatan Republik Indonesia, Politeknik Kesehatan Palembang, Jurusan Farmasi, Surat Pernyataan, and Integritas Karya. 2019. “Monitoring Kepatuhan Minum Obat Dan Kadar Gula , Serta Tekanan Darah Penderita Diabetes Militus Palembang.”